Teladoc Health, Inc.

TDOC Healthcare Health Information Services

Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

5.67 0.30 −5.03%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
−7.7×
Dividend yield
—
F-score
5/9
Altman Z
−6.66
Beneish M
−3.26
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 5 5 5
ROE
(15.42%) (13.93%) (12.39%) (12.99%)
ROA
(6.98%) (6.28%) (5.48%) (6.28%)
ROIC
(10.36%) (10.27%) (8.07%) (7.62%)
Return on Tangible Assets
(31.29%) (27.02%) (22.71%) 85.01%
Average Days of Receivables
30.43 27.82 31.01 32.40
Free Cash Flow per Share
0.61 0.78 0.87 0.49
Free Cash Flow
108.31 137.33 156.26 88.56
Other line items

Show all line items

Columns are period end dates